SAB Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 05/15/2025 | 917.83 K | $1.24 M | 0.00% | 9.88% |
| SESSA CAPITAL IM, L.P. | 05/15/2025 | 458.46 K | $623.50 K | 0.00% | 4.93% |
| VANGUARD GROUP INC | 05/09/2025 | 277.51 K | $374.64 K | 0.05% | 2.99% |
| HB WEALTH MANAGEMENT, LLC | 05/07/2025 | 263.20 K | $357.95 K | 10.87% | 2.83% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 84.69 K | $114.34 K | 5.55% | 0.91% |
| PATHSTONE HOLDINGS, LLC | 05/15/2025 | 50.65 K | $68.89 K | 0.00% | 0.55% |
| BLACKROCK, INC. | 05/02/2025 | 22.30 K | $30.33 K | -1.34% | 0.24% |
| SILVER OAK SECURITIES, INCORPORATED | 04/29/2025 | 20.19 K | $29.88 K | 100.00% | 0.22% |
| KOVITZ INVESTMENT GROUP PARTNERS, LLC | 05/19/2025 | 19.20 K | $26.11 K | 0.00% | 0.21% |
| FIRST PREMIER BANK | 04/22/2025 | 18.99 K | $26.00 K | 0.00% | 0.20% |
| XTX TOPCO LTD | 05/08/2025 | 16.56 K | $22.35 K | 100.00% | 0.18% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 16.35 K | $22.07 K | -44.41% | 0.18% |
| KESTRA ADVISORY SERVICES, LLC | 05/14/2025 | 11.93 K | $16.23 K | 0.00% | 0.13% |
| NORTHERN TRUST CORP | 05/13/2025 | 11.39 K | $15.49 K | 0.00% | 0.12% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 10.03 K | $13.64 K | 100.00% | 0.11% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 4.95 K | $6.73 K | -1.98% | 0.05% |
| SACHETTA, LLC | 05/02/2025 | 4.10 K | $5.58 K | 4,000.00% | 0.04% |
| MORGAN STANLEY | 05/15/2025 | 449 | $610 | -25.04% | 0.00% |
| MAI CAPITAL MANAGEMENT | 05/15/2025 | 217 | $296 | 66.92% | 0.00% |
| GS INVESTMENTS, INC. | 05/08/2025 | 200 | $272 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/12/2025 | 103 | $139 | -1.90% | 0.00% |
| UBS GROUP AG | 05/13/2025 | 78 | $106 | -92.80% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 67 | $91 | 4.69% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 05/08/2025 | 50 | $68 | 0.00% | 0.00% |
| 05/02/2025 | 50 | $68 | 100.00% | 0.00% | |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 34 | $46 | -95.96% | 0.00% |
| MARSHALL WACE, LLP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
SAB Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 33 institutional investors and hedge funds held shares of SAB Biotherapeutics, Inc.. The most heavily invested institutionals were:
BVF INC/IL: 917,826
Sessa Capital IM, L.P.: 458,457
VANGUARD GROUP INC: 277,510
HB Wealth Management, LLC: 263,200
GEODE CAPITAL MANAGEMENT, LLC: 84,685
Pathstone Holdings, LLC: 50,650
23.78% of SAB Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.28 M shares in the last 24 months. This purchase volume represents approximately $6.10 M in transactions.